OPTION CARE HEALTH, INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2017-12-01: Form 8-K; Exhibit 10.1; Description Offer Letter, dated as of November 29, 2017, by and between BioScrip, Inc. and Anthony “Tony” Lopez..
- 2017-11-28: Form 8-K; Exhibit 10.1; Description Offer Letter, dated as of November 21, 2017, by and between BioScrip, Inc. and Harriet Booker..
- 2017-06-29: Form 8-K; Exhibit 10.6; Description Stock Purchase Agreement, dated as of June 29, 2017, by and among the Company and the purchaser signatory thereto..
- 2017-06-29: Form 8-K; Exhibit 10.5; Description Warrant Purchase Agreement, dated as of June 29, 2017, by and among the Company and the subscribers signatory thereto..
| Filed | Form | Exhibit | Description |
|---|
| 2017-12-01 | 8-K | 10.1 | Offer Letter, dated as of November 29, 2017, by and between BioScrip, Inc. and Anthony “Tony” Lopez. |
|---|
| 2017-11-28 | 8-K | 10.1 | Offer Letter, dated as of November 21, 2017, by and between BioScrip, Inc. and Harriet Booker. |
|---|
| 2017-06-29 | 8-K | 10.6 | Stock Purchase Agreement, dated as of June 29, 2017, by and among the Company and the purchaser signatory thereto. |
|---|
| 2017-06-29 | 8-K | 10.5 | Warrant Purchase Agreement, dated as of June 29, 2017, by and among the Company and the subscribers signatory thereto. |
|---|
| 2017-06-29 | 8-K | 10.4 | Second Lien Guaranty and Security Agreement, dated as of June 29, 2017, by and the Company, the subsidiaries of the Company signatory thereto and Wells Fargo Bank, National Association as Collateral Agent. |
|---|
| 2017-06-29 | 8-K | 10.3 | Second Lien Note Purchase Agreement, dated as of June 29, 2017, by and among the Company, the financial institutions and note purchasers from time to time party thereto, and Wells Fargo Bank, National Association as Collateral Agent. |
|---|
| 2017-06-29 | 8-K | 10.2 | First Lien Guaranty and Security Agreement, dated as of June 29, 2017, by and the Company, the subsidiaries of the Company signatory thereto and Wells Fargo Bank, National Association as Collateral Agent. |
|---|
| 2017-06-29 | 8-K | 10.1 | First Lien Note Purchase Agreement, dated as of June 29, 2017, by and among the Company, the financial institutions and note purchasers from time to time party thereto, and Wells Fargo Bank, National Association, as Collateral Agent. |
|---|
| 2017-04-20 | 8-K | 10.1 | Offer Letter, dated as of April 10, 2017, by and between BioScrip, Inc. and Stephen M. Deitsch. |
|---|
| 2017-03-02 | 8-K | 10.1 | Stock Purchase Agreement, dated March 1, 2017, by and among the Company and the investors named therein. |
|---|
| 2017-01-09 | 8-K | 10.2 | Priming Credit Agreement, dated as of January 6, 2017, by and among the Company, SunTrust Bank and the lenders from time to time party thereto. |
|---|
| 2017-01-09 | 8-K | 10.1 | Sixth Amendment to the Senior Credit Facilities, dated as of January 6, 2017. |
|---|